» Articles » PMID: 27903996

Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors

Overview
Specialty Nephrology
Date 2016 Dec 2
PMID 27903996
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study aimed to evaluate the outcome and predictors of survival in hemodialysis patients of Hasheminejad Kidney Center where a comprehensive dialysis care program has been placed since 2004.

Materials And Methods: Data of 560 hemodialysis patients were used to evaluate 9-year survival rates and predictors of mortality. Cox regression models included comorbidities as well as averaged and 6-month-averaged time-dependent values of laboratory findings as independent factors.

Results: Survival rates were 91.9%, 66.0%, 46.3%, and 28.5%,  at 1, 3, 5, and 9 years, respectively, in all patients and 90.8%, 61.6%, 42.1%, and 28.0% in 395 incident patients starting hemodialysis after 2004. Adjusted survival models demonstrated age, male sex, diabetes mellitus, cardiovascular disease, and high-risk vascular access as baseline predictors of mortality, as well as averaged low hemoglobin level (hazard ratio [HR], 1.98; 95% confidence interval [CI], 1.36 to 2.90) and a single-pool KT/V < 1.2 (HR, 2.28; 95% CI, 1.60 to 3.26). The averaged high-density lipoprotein cholesterol (HR, 0.67; 95% CI, 0.55 to 0.81) and serum creatinine (HR, 0.71; 95% CI, 0.64 to 0.79) levels demonstrated protective effects. The adjusted time-dependent model further revealed the significant association of hypocalcemia (HR, 1.63; 95% CI, 1.13 to 2.34), hypercalcemia (HR, 1.50; 95% CI, 1.02 to 2.21), and hyperphosphatemia (HR, 1.68; 95% CI, 1.20 to 2.37) with death.

Conclusions: Our patients have relatively comparable survival rates with high-profile dialysis centers. Aiming to better achieve the recommended targets, especially hemoglobin and nutritional and bone metabolism factors, should be considered for optimal dialysis outcomes.

Citing Articles

Evaluation of laboratory values affecting mortality of end-stage renal disease patients: a competing risks approach.

Malek R, Baghestani A, Rashid-Farokhi F, Shafaghi S, Minoo F, Eghbali F BMC Nephrol. 2023; 24(1):213.

PMID: 37464291 PMC: 10353130. DOI: 10.1186/s12882-023-03234-x.


The association between dose of hemodialysis and patients mortality in a prospective cohort study.

Liu S, Wang Z, Zhang S, Xiao J, You L, Zhang Y Sci Rep. 2022; 12(1):13708.

PMID: 35962178 PMC: 9374660. DOI: 10.1038/s41598-022-17943-0.


International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East.

Amouzegar A, Abu-Alfa A, Alrukhaimi M, Bello A, Ghnaimat M, Johnson D Kidney Int Suppl (2011). 2021; 11(2):e47-e56.

PMID: 33981470 PMC: 8084726. DOI: 10.1016/j.kisu.2021.01.002.


The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review.

Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O Int J Nephrol. 2020; 2020:7692376.

PMID: 32665863 PMC: 7349626. DOI: 10.1155/2020/7692376.